vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and GCM Grosvenor Inc. (GCMG). Click either name above to swap in a different company.

GCM Grosvenor Inc. is the larger business by last-quarter revenue ($177.1M vs $121.8M, roughly 1.5× Core Laboratories Inc.). GCM Grosvenor Inc. runs the higher net margin — 32.8% vs 4.2%, a 28.6% gap on every dollar of revenue. On growth, GCM Grosvenor Inc. posted the faster year-over-year revenue change (7.2% vs -1.4%). GCM Grosvenor Inc. produced more free cash flow last quarter ($175.0M vs $517.0K). Over the past eight quarters, GCM Grosvenor Inc.'s revenue compounded faster (27.5% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

GCM Grosvenor is an American alternative asset management firm, with approximately $76 billion in assets under management and approximately 530 professionals as of 2023.

CLB vs GCMG — Head-to-Head

Bigger by revenue
GCMG
GCMG
1.5× larger
GCMG
$177.1M
$121.8M
CLB
Growing faster (revenue YoY)
GCMG
GCMG
+8.6% gap
GCMG
7.2%
-1.4%
CLB
Higher net margin
GCMG
GCMG
28.6% more per $
GCMG
32.8%
4.2%
CLB
More free cash flow
GCMG
GCMG
$174.5M more FCF
GCMG
$175.0M
$517.0K
CLB
Faster 2-yr revenue CAGR
GCMG
GCMG
Annualised
GCMG
27.5%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
GCMG
GCMG
Revenue
$121.8M
$177.1M
Net Profit
$5.1M
$58.2M
Gross Margin
Operating Margin
1.5%
30.9%
Net Margin
4.2%
32.8%
Revenue YoY
-1.4%
7.2%
Net Profit YoY
149.2%
EPS (diluted)
$0.11
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
GCMG
GCMG
Q1 26
$121.8M
Q4 25
$138.3M
$177.1M
Q3 25
$134.5M
$135.0M
Q2 25
$130.2M
$119.7M
Q1 25
$123.6M
$125.8M
Q4 24
$129.2M
$165.3M
Q3 24
$134.4M
$122.9M
Q2 24
$130.6M
$117.0M
Net Profit
CLB
CLB
GCMG
GCMG
Q1 26
$5.1M
Q4 25
$4.9M
$58.2M
Q3 25
$14.2M
$10.5M
Q2 25
$10.6M
$15.4M
Q1 25
$-154.0K
$463.0K
Q4 24
$7.4M
$7.6M
Q3 24
$11.7M
$4.2M
Q2 24
$9.0M
$4.8M
Gross Margin
CLB
CLB
GCMG
GCMG
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
GCMG
GCMG
Q1 26
1.5%
Q4 25
11.5%
30.9%
Q3 25
15.6%
32.7%
Q2 25
11.7%
16.1%
Q1 25
3.6%
12.2%
Q4 24
11.0%
26.4%
Q3 24
14.7%
20.3%
Q2 24
12.3%
17.8%
Net Margin
CLB
CLB
GCMG
GCMG
Q1 26
4.2%
Q4 25
3.6%
32.8%
Q3 25
10.6%
7.8%
Q2 25
8.2%
12.9%
Q1 25
-0.1%
0.4%
Q4 24
5.7%
4.6%
Q3 24
8.7%
3.4%
Q2 24
6.9%
4.1%
EPS (diluted)
CLB
CLB
GCMG
GCMG
Q1 26
$0.11
Q4 25
$0.11
$0.23
Q3 25
$0.30
$0.16
Q2 25
$0.22
$0.05
Q1 25
$0.00
$-0.02
Q4 24
$0.15
$0.09
Q3 24
$0.25
$0.03
Q2 24
$0.19
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
GCMG
GCMG
Cash + ST InvestmentsLiquidity on hand
$22.8M
$242.1M
Total DebtLower is stronger
$428.4M
Stockholders' EquityBook value
$275.1M
$27.0M
Total Assets
$587.7M
$813.8M
Debt / EquityLower = less leverage
15.87×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
GCMG
GCMG
Q1 26
$22.8M
Q4 25
$22.7M
$242.1M
Q3 25
$25.6M
$182.7M
Q2 25
$31.2M
$136.3M
Q1 25
$22.1M
$94.5M
Q4 24
$19.2M
$89.5M
Q3 24
$21.5M
$98.4M
Q2 24
$17.7M
$73.9M
Total Debt
CLB
CLB
GCMG
GCMG
Q1 26
Q4 25
$110.3M
$428.4M
Q3 25
$114.1M
$429.3M
Q2 25
$124.6M
$430.2M
Q1 25
$124.4M
$431.1M
Q4 24
$126.1M
$432.0M
Q3 24
$139.9M
$432.9M
Q2 24
$147.6M
$433.8M
Stockholders' Equity
CLB
CLB
GCMG
GCMG
Q1 26
$275.1M
Q4 25
$266.0M
$27.0M
Q3 25
$271.3M
$-7.4M
Q2 25
$261.3M
$-12.3M
Q1 25
$253.4M
$-28.3M
Q4 24
$246.6M
$-27.6M
Q3 24
$250.7M
$-31.9M
Q2 24
$240.3M
$-28.5M
Total Assets
CLB
CLB
GCMG
GCMG
Q1 26
$587.7M
Q4 25
$584.0M
$813.8M
Q3 25
$591.4M
$685.9M
Q2 25
$602.1M
$636.9M
Q1 25
$591.5M
$579.8M
Q4 24
$585.1M
$612.7M
Q3 24
$600.5M
$575.0M
Q2 24
$597.8M
$543.9M
Debt / Equity
CLB
CLB
GCMG
GCMG
Q1 26
Q4 25
0.41×
15.87×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
GCMG
GCMG
Operating Cash FlowLast quarter
$4.0M
$183.5M
Free Cash FlowOCF − Capex
$517.0K
$175.0M
FCF MarginFCF / Revenue
0.4%
98.8%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
0.77×
3.16×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$326.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
GCMG
GCMG
Q1 26
$4.0M
Q4 25
$7.9M
$183.5M
Q3 25
$8.5M
$79.8M
Q2 25
$13.9M
$42.0M
Q1 25
$6.7M
$33.3M
Q4 24
$20.6M
$148.8M
Q3 24
$13.1M
$69.0M
Q2 24
$17.1M
$17.5M
Free Cash Flow
CLB
CLB
GCMG
GCMG
Q1 26
$517.0K
Q4 25
$5.0M
$175.0M
Q3 25
$6.5M
$78.3M
Q2 25
$10.4M
$40.8M
Q1 25
$3.9M
$32.1M
Q4 24
$17.4M
$132.0M
Q3 24
$10.4M
$62.2M
Q2 24
$14.3M
$12.8M
FCF Margin
CLB
CLB
GCMG
GCMG
Q1 26
0.4%
Q4 25
3.6%
98.8%
Q3 25
4.8%
58.0%
Q2 25
8.0%
34.1%
Q1 25
3.1%
25.5%
Q4 24
13.4%
79.9%
Q3 24
7.7%
50.6%
Q2 24
10.9%
10.9%
Capex Intensity
CLB
CLB
GCMG
GCMG
Q1 26
Q4 25
2.1%
4.8%
Q3 25
1.5%
1.1%
Q2 25
2.7%
1.0%
Q1 25
2.3%
0.9%
Q4 24
2.5%
10.1%
Q3 24
2.0%
5.5%
Q2 24
2.2%
4.0%
Cash Conversion
CLB
CLB
GCMG
GCMG
Q1 26
0.77×
Q4 25
1.61×
3.16×
Q3 25
0.60×
7.61×
Q2 25
1.31×
2.72×
Q1 25
71.84×
Q4 24
2.78×
19.54×
Q3 24
1.12×
16.60×
Q2 24
1.90×
3.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

GCMG
GCMG

Asset Management1$108.6M61%
Management Service Incentive Performance Fees$61.7M35%
Management Service Incentive Carried Interest$5.1M3%
Service Other$1.8M1%

Related Comparisons